Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

NCT04180813 · clinicaltrials.gov ↗

TERMINATED

Status

85

Enrollment

INDUSTRY

Sponsor class

Stopped Study enrollment did not meet expectation.

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Linagliptin
DRUG: Acarbose

Sponsor

Boehringer Ingelheim